Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins.

Odeberg J, Browne H, Metkar S, Froelich CJ, Brandén L, Cosman D, Söderberg-Nauclér C.

J Virol. 2003 Apr;77(8):4539-45.

2.

Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.

Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.

J Immunol. 2003 Jul 15;171(2):902-8.

3.
4.

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, Cosman D.

J Exp Med. 2003 Jun 2;197(11):1427-39.

6.

Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus.

Bennett NJ, Ashiru O, Morgan FJ, Pang Y, Okecha G, Eagle RA, Trowsdale J, Sissons JG, Wills MR.

J Immunol. 2010 Jul 15;185(2):1093-102. doi: 10.4049/jimmunol.1000789. Epub 2010 Jun 7.

7.
8.

Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme M-mediated cleavage of viral phosphoprotein 71.

van Domselaar R, Philippen LE, Quadir R, Wiertz EJ, Kummer JA, Bovenschen N.

J Immunol. 2010 Dec 15;185(12):7605-13. doi: 10.4049/jimmunol.1001503. Epub 2010 Nov 8.

9.

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.

Welte SA, Sinzger C, Lutz SZ, Singh-Jasuja H, Sampaio KL, Eknigk U, Rammensee HG, Steinle A.

Eur J Immunol. 2003 Jan;33(1):194-203.

10.

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.

11.

Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression.

Koga T, Harada H, Shi TS, Okada S, Suico MA, Shuto T, Kai H.

Biochem Biophys Res Commun. 2005 Dec 2;337(4):1319-23. Epub 2005 Oct 10.

PMID:
16236268
12.

Human NK cells lyse porcine endothelial cells via the perforin/granzyme B pathway.

Matter-Reissmann UB, Forte P, Seebach JD.

Transplant Proc. 2001 Feb-Mar;33(1-2):439-40. No abstract available.

PMID:
11266899
13.

Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo.

Portales P, Reynes J, Pinet V, Rouzier-Panis R, Baillat V, Clot J, Corbeau P.

AIDS. 2003 Mar 7;17(4):495-504.

PMID:
12598769
14.
16.

The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.

Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B.

Cancer Immunol Immunother. 1997 Jul;44(5):282-90.

PMID:
9247563
17.

Reduction of perforin, granzyme B, and cytokine interferon gamma by ethanol in male Fischer 344 rats.

Dokur M, Boyadjieva NI, Sarkar DK.

Alcohol Clin Exp Res. 2003 Apr;27(4):670-6.

PMID:
12711929
18.

KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.

Suck G, Branch DR, Smyth MJ, Miller RG, Vergidis J, Fahim S, Keating A.

Exp Hematol. 2005 Oct;33(10):1160-71.

PMID:
16219538
19.
20.

Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.

Cerboni C, Mousavi-Jazi M, Linde A, Söderström K, Brytting M, Wahren B, Kärre K, Carbone E.

J Immunol. 2000 May 1;164(9):4775-82.

Supplemental Content

Support Center